Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Liver/metabolism/pathology"'
Autor:
François R Jornayvaz, Mohamed Asrih
Publikováno v:
Molecular and Cellular Endocrinology, Vol. 418, No Pt 1 (2015) pp. 55-65
Metabolic syndrome (MetS) is a disease composed of different risk factors such as obesity, type 2 diabetes or dyslipidemia. The prevalence of this syndrome is increasing worldwide in parallel with the rise in obesity. Nonalcoholic fatty liver disease
Autor:
Kévin Guilloux, Andrea Sanchez-Pareja, Manlio Vinciguerra, Lucie Bourgoin, David M. Suter, Stéphanie Pascarella, Francesco Negro, Sophie Clément, Marion Peyrou, Laura Rubbia-Brandt, Michelangelo Foti, Pierluigi Ramadori
Publikováno v:
Hepatology (Baltimore Md.)
Hepatology, Vol. 54, No 1 (2011) pp. 38-49
Hepatology, Vol. 54, No 1 (2011) pp. 38-49
Hepatitis C virus (HCV) perturbs the host's lipid metabolism and often results in hepatic steatosis. In nonalcoholic fatty liver disease, the intrahepatic down-regulation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a critical
Autor:
Okubo, H., Sakoda, H., Kushiyama, A., Fujishiro, M., Nakatsu, Y., Fukushima, Toshiaki, Matsunaga, Y., Kamata, H., Asahara, T., Yoshida, Y., Chonan, O., Iwashita, M., Nishimura, F., Asano, T.
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 305:G911-G918
Gut microbiota alterations are associated with various disorders. In this study, gut microbiota changes were investigated in a methionine-choline-deficient (MCD) diet-induced nonalcoholic steatohepatitis (NASH) rodent model, and the effects of admini
Publikováno v:
Thrombosis and Haemostasis; Vol 110
Thrombosis and Haemostasis, Vol. 110, No 5 (2013) pp. 940-958
Thrombosis and Haemostasis
Thrombosis and haemostasis
Thrombosis and Haemostasis, Vol. 110, No 5 (2013) pp. 940-958
Thrombosis and Haemostasis
Thrombosis and haemostasis
SummaryThe increased atherothrombotic risk in patients with metabolic syndrome (MetS) has been classically explained by the multiplicative effect of systemic concomitant pro-atherosclerotic factors. In particular, centripetal obesity, dyslipidaemia,
Autor:
Nathalie Lin-Marq, Laurent Spahr, Nicolas Goossens, Laura Rubbia-Brandt, Sophie Clément, Nicolas Lanthier
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-10 (2017)
Stem Cell Research & Therapy, Vol. 8, No 1 (2017) P. 88
Stem Cell Research & Therapy, Vol. 8, no. 1, p. 88 [1-10] (2017)
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-10 (2017)
Stem Cell Research & Therapy, Vol. 8, No 1 (2017) P. 88
Stem Cell Research & Therapy, Vol. 8, no. 1, p. 88 [1-10] (2017)
Background Liver stem cell therapy (SCT) has been suggested as a promising means to improve liver regeneration in advanced liver disease. However, data from trials are heterogeneous, with no systematic histological evaluation. The aim of this study i
Autor:
Benoit Terris, Laura Rubbia-Brandt, Gilles Mentha, Sébastien Tauzin, Céline Delucinge-Vivier, Bertrand Dousset, Patrick Descombes, Catherine Brezault, Pietro Majno
Publikováno v:
Molecular Cancer Therapeutics, Vol. 10, No 4 (2011) pp. 687-96
Sinusoidal obstruction syndrome (SOS; formerly veno-occlusive disease) is a well-established complication of hematopoietic stem cell transplantation, pyrrolizidine alkaloid intoxication, and widely used chemotherapeutic agents such as oxaliplatin. It
Autor:
Hasenfuss, Sebastian C., Bakiri, Latifa, Thomsen, Martin K., Williams, Evan, Auwerx, Johan, Wagner, Erwin F.
Nonalcoholic fatty liver disease (NAFLD) affects up to 30% of the adult population in Western societies, yet the underlying molecular pathways remain poorly understood. Here, we identify the dimeric Activator Protein 1 as a regulator of NAFLD. Fos-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2658::5e08a96f66155b6c5ba4737093f00048
http://orbilu.uni.lu/handle/10993/43162
http://orbilu.uni.lu/handle/10993/43162
Autor:
Jennifer W. Hill, Jens C. Brüning, Jeffrey Iler, Streamson C. Chua, Joseph S. Marino, Abigail R. Dowling, Roberto Coppari
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e48643 (2012)
PLOS ONE, Vol. 7, No 10 (2012) P. e48643
PLoS ONE, Vol 7, Iss 10, p e48643 (2012)
PLOS ONE, Vol. 7, No 10 (2012) P. e48643
Clinical research shows an association between polycystic ovary syndrome (PCOS) and chronic inflammation, a pathological state thought to contribute to insulin resistance. The underlying pathways, however, have not been defined. The purpose of this s
Autor:
Franco Folli, Per Westermark, Tatsuya Kin, Arne Andersson, A. M. James Shapiro, Alberto M. Davalli, Gunnar Tufveson, Gunilla T. Westermark, Antonio Secchi, Olle Korsgren, Christian Toso
Publikováno v:
Transplantation, Vol. 93, No 2 (2012) pp. 219-23
Background. The reasons for the long-term complete or partial loss of islet graft function are unknown, but there areobviously other reasons than just pure allogeneic graft rejection. Earlier studies have shown that deposition of isletamyloid polypep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470a6d8fc66ad648c9adf49371aee425
Publikováno v:
The American journal of pathology
The American journal of pathology, 2011, 178 (2), pp.774-83. ⟨10.1016/j.ajpath.2010.10.004⟩
The American journal of pathology, 2011, 178 (2), pp.774-83. ⟨10.1016/j.ajpath.2010.10.004⟩
International audience; beta-Thalassemia and pseudoxanthoma elasticum (PXE) are distinct genetic disorders. Yet, a dystrophic mineralization phenotype similar to PXE has frequently been associated with beta-thalassemia or sickle cell anemia patients